Data supplements
Online Appendix
Files in this Data Supplement:
In this issue
Article tools
Respond to this article
Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysis
Jump to section
Related Articles
Cited By...
- Analysis of the effect of proton pump inhibitors on the course of common COVID-19
- How do potentially inappropriate medications and polypharmacy affect mortality in frail and non-frail cognitively impaired older adults? A cohort study
- Randomised, double-blind, placebo-controlled pilot trial of omeprazole in idiopathic pulmonary fibrosis
- Nutritional and Gastrointestinal Management of the Patient With Duchenne Muscular Dystrophy
- Toxicity of long-term use of proton pump inhibitors in children
- Risk of death among users of Proton Pump Inhibitors: a longitudinal observational cohort study of United States veterans
- Prophylactic Acid-Suppressive Therapy in Hospitalized Adults: Indications, Benefits, and Infectious Complications
- DTB Select: 2 | February 2017
- Proton pump inhibitors and community acquired pneumonia
- Community acquired pneumonia incidence before and after proton pump inhibitor prescription: population based study
- Potential harms of proton pump inhibitor therapy: rare adverse effects of commonly used drugs
- Multinational, double-blind, randomised, placebo-controlled, prospective study of esomeprazole in the prevention of recurrent peptic ulcer in low-dose acetylsalicylic acid users: the LAVENDER study
- Proton pump inhibitors and the risk of hospitalisation for community-acquired pneumonia: replicated cohort studies with meta-analysis
- Are there risks associated with empiric acid suppression treatment of infants and children suspected of having gastroesophageal reflux disease?
- Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysis
- Microbial evaluation of proton-pump inhibitors and the risk of pneumonia
- PPIs: too much of a good thing?